An expanded diagnostic suite based on immunohistochemistry (IHC) technology, in which eleven specific immunohistochemical markers (antigens) are applied and evaluated on tissue slides. This comprehensive suite identifies the characteristic immunophenotypes of cells, enabling pathologists to accurately classify tumors, determine their histological origin, and identify prognostic and therapeutic indicators.